Altered Expression of MiRNAs in a Dihydrotestosterone-induced Rat PCOS Model

Overview

Journal J Ovarian Res

Publisher Biomed Central

Specialties Gynecology & Obstetrics
Reproductive Medicine

Date 2013 May 17

PMID 23675970

Citations 40

Authors

Md Munir Hossain

Mingju Cao

Qi Wang

Ji Young Kim

Karl Schellander

Dawit Tesfaye

Benjamin K Tsang

Affiliations

Soon will be listed here.

Abstract

Background: The polycystic ovary syndrome (PCOS) is a complex and heterogeneous endocrine condition characterized by hyperandrogenism, hyperinsulinemia, insulin resistance and chronic anovulation. Regulation and interaction of a multitude of genes required for follicular development are found to be altered in PCOS. MicroRNAs (miRNAs) mediate posttranscriptional gene regulation by binding to the 3´ untranslated region of mRNAs to either inhibit or enhance translation. However, the extent and regulation of miRNA expression in PCOS is poorly understood and the current study is the first to describe altered expression of miRNAs in PCOS.

Methods: A chronically androgenized [5α-dihydrotestosterone (DHT)-treated] rat model which recapitulates many of the phenotypes of human PCOS, and miRNA PCR array was used to investigate the expression of 349 miRNAs in DHT treated rat ovaries. The ovarian expression of several selected miRNAs was also analyzed by in situ localization experiment.

Results: DHT-treated rats exhibit increased body weight, disrupted estrus cyclicity, decreased insulin sensitivity and decreased ovarian weight, with the latter phenomenon readily rescued by gonadotropin treatment in vivo. In general, 24% of the 349 miRNAs investigated were found to be differentially expressed between DHT-treated and control rats. Most of the differentially expressed miRNAs were found to be predominantly localized in the theca cells of the follicles. In silico analysis of the potential target genes of dysregulated miRNAs revealed their possible involvement in various pathways in the regulation of ovarian function.

Conclusion: Our current findings suggest that miRNAs are differentially regulated in hyperandrogenism, a condition possibly involved in the dysregulation of steroid hormone receptors and intra-ovarian factors, and that miRNAs may be involved in the etiology of PCOS.

Citing Articles

Ameliorative effect of Fagonia indica-coated chitosan nanoparticles on the ovulatory pattern in PCOS rat model.

Zia T, Liaqat I, Shahzad K, Lashari M, Fouad D, Ataya F J Ovarian Res. 2025; 18(1):44.

PMID: 40050951 PMC: 11887359. DOI: 10.1186/s13048-025-01635-0.

Whole transcriptome analysis revealed the regulatory network and related pathways of non-coding RNA regulating ovarian atrophy in broody hens.

Xiong H, Li W, Wang L, Wang X, Tang B, Cui Z Front Vet Sci. 2024; 11:1399776.

PMID: 38868501 PMC: 11168117. DOI: 10.3389/fvets.2024.1399776.

Consumption of soya isoflavones improved polycystic ovary syndrome-associated metabolic disorders in a rat model.

Xiao C, Carbonel A, Lima P, Hendry A, Tsang B Br J Nutr. 2024; :1-9.

PMID: 38826091 PMC: 11499085. DOI: 10.1017/S0007114524001296.

A glance into the roles of microRNAs (exosomal and non-exosomal) in polycystic ovary syndrome.

Masoudi Chelegahi A, Ebrahimi S, Reiisi S, Nezamnia M Obstet Gynecol Sci. 2023; 67(1):30-48.

PMID: 38050353 PMC: 10792310. DOI: 10.5468/ogs.23193.

Differential expression of plasma‑derived exosomal miRNAs in polycystic ovary syndrome as a circulating biomarker.

Liu Y, Shi X, Xu B, Wang Z, Chen Y, Deng M Biomed Rep. 2023; 19(6):92.

PMID: 37901874 PMC: 10603371. DOI: 10.3892/br.2023.1674.

References

Wood J, Dumesic D, Abbott D, Strauss 3rd J . Molecular abnormalities in oocytes from women with polycystic ovary syndrome revealed by microarray analysis. J Clin Endocrinol Metab. 2006; 92(2):705-13. DOI: 10.1210/jc.2006-2123. View

Hughes C, Elgasim M, Layfield R, Atiomo W . Genomic and post-genomic approaches to polycystic ovary syndrome--progress so far: Mini Review. Hum Reprod. 2006; 21(11):2766-75. DOI: 10.1093/humrep/del222. View

Jakimiuk A, Weitsman S, Yen H, Bogusiewicz M, Magoffin D . Estrogen receptor alpha and beta expression in theca and granulosa cells from women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2002; 87(12):5532-8. DOI: 10.1210/jc.2002-020323. View

Mattie M, Benz C, Bowers J, Sensinger K, Wong L, Scott G . Optimized high-throughput microRNA expression profiling provides novel biomarker assessment of clinical prostate and breast cancer biopsies. Mol Cancer. 2006; 5:24. PMC: 1563474. DOI: 10.1186/1476-4598-5-24. View

Wachs D, Coffler M, Malcom P, Shimasaki S, Chang R . Increased androgen response to follicle-stimulating hormone administration in women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2008; 93(5):1827-33. PMC: 2386684. DOI: 10.1210/jc.2007-2664. View

Yao N, Yang B, Liu Y, Tan X, Lu C, Yuan X . Follicle-stimulating hormone regulation of microRNA expression on progesterone production in cultured rat granulosa cells. Endocrine. 2010; 38(2):158-66. DOI: 10.1007/s12020-010-9345-1. View

Franks S . Polycystic ovary syndrome. N Engl J Med. 1995; 333(13):853-61. DOI: 10.1056/NEJM199509283331307. View

Hossain M, Ghanem N, Hoelker M, Rings F, Phatsara C, Tholen E . Identification and characterization of miRNAs expressed in the bovine ovary. BMC Genomics. 2009; 10:443. PMC: 2762473. DOI: 10.1186/1471-2164-10-443. View

Legro R, Barnhart H, Schlaff W, Carr B, Diamond M, Carson S . Clomiphene, metformin, or both for infertility in the polycystic ovary syndrome. N Engl J Med. 2007; 356(6):551-66. DOI: 10.1056/NEJMoa063971. View

10.

Motta A . Dehydroepiandrosterone to induce murine models for the study of polycystic ovary syndrome. J Steroid Biochem Mol Biol. 2010; 119(3-5):105-11. DOI: 10.1016/j.jsbmb.2010.02.015. View

11.

Krek A, Grun D, Poy M, Wolf R, Rosenberg L, Epstein E . Combinatorial microRNA target predictions. Nat Genet. 2005; 37(5):495-500. DOI: 10.1038/ng1536. View

12.

Cardenas H, Herrick J, Pope W . Increased ovulation rate in gilts treated with dihydrotestosterone. Reproduction. 2002; 123(4):527-33. DOI: 10.1530/rep.0.1230527. View

13.

Zhao Y, Deng C, Wang J, Xiao J, Gatalica Z, Recker R . Let-7 family miRNAs regulate estrogen receptor alpha signaling in estrogen receptor positive breast cancer. Breast Cancer Res Treat. 2010; 127(1):69-80. DOI: 10.1007/s10549-010-0972-2. View

14.

Tang F, Kaneda M, OCarroll D, Hajkova P, Barton S, Sun Y . Maternal microRNAs are essential for mouse zygotic development. Genes Dev. 2007; 21(6):644-8. PMC: 1820938. DOI: 10.1101/gad.418707. View

15.

Obernosterer G, Martinez J, Alenius M . Locked nucleic acid-based in situ detection of microRNAs in mouse tissue sections. Nat Protoc. 2007; 2(6):1508-14. DOI: 10.1038/nprot.2007.153. View

16.

Brawer J, Schipper H, Robaire B . Effects of long term androgen and estradiol exposure on the hypothalamus. Endocrinology. 1983; 112(1):194-9. DOI: 10.1210/endo-112-1-194. View

17.

Sirotkin A, Ovcharenko D, Grossmann R, Laukova M, Mlyncek M . Identification of microRNAs controlling human ovarian cell steroidogenesis via a genome-scale screen. J Cell Physiol. 2009; 219(2):415-20. DOI: 10.1002/jcp.21689. View

18.

Nam E, Yoon H, Kim S, Kim H, Kim Y, Kim J . MicroRNA expression profiles in serous ovarian carcinoma. Clin Cancer Res. 2008; 14(9):2690-5. DOI: 10.1158/1078-0432.CCR-07-1731. View

19.

Diao F, Xu M, Hu Y, Li J, Xu Z, Lin M . The molecular characteristics of polycystic ovary syndrome (PCOS) ovary defined by human ovary cDNA microarray. J Mol Endocrinol. 2004; 33(1):59-72. DOI: 10.1677/jme.0.0330059. View

20.

Fiedler S, Carletti M, Hong X, Christenson L . Hormonal regulation of MicroRNA expression in periovulatory mouse mural granulosa cells. Biol Reprod. 2008; 79(6):1030-7. PMC: 2780477. DOI: 10.1095/biolreprod.108.069690. View